(ANTI)-3-[[4-(4-CHLOROPHENYL)-PIPERAZIN-1-YL]-METHYL]-4-METHYL-5-THIEN-2-YL-1,3-OXAZOLIDIN-2-ONE
Compound with spectra: 1 NMR
![(ANTI)-3-[[4-(4-CHLOROPHENYL)-PIPERAZIN-1-YL]-METHYL]-4-METHYL-5-THIEN-2-YL-1,3-OXAZOLIDIN-2-ONE](/api/compound/KEhbIhiZdZK.png?ph=true&h=300&w=458 "(ANTI)-3-[[4-(4-CHLOROPHENYL)-PIPERAZIN-1-YL]-METHYL]-4-METHYL-5-THIEN-2-YL-1,3-OXAZOLIDIN-2-ONE")
| SpectraBase Compound ID | KEhbIhiZdZK |
|---|---|
| InChI | InChI=1S/C19H22ClN3O2S/c1-14-18(17-3-2-12-26-17)25-19(24)23(14)13-21-8-10-22(11-9-21)16-6-4-15(20)5-7-16/h2-7,12,14,18H,8-11,13H2,1H3/t14-,18+/m0/s1 |
| InChIKey | KQGVHFHOXZUGLF-KBXCAEBGSA-N |
| Mol Weight | 391.92 g/mol |
| Molecular Formula | C19H22ClN3O2S |
| Exact Mass | 391.112126 g/mol |
| Enantiomer InChIKey | KQGVHFHOXZUGLF-KDOFPFPSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[(4-Phenyl-1-piperazinyl)methyl]-1H-indole-2,3-dione
(3S)-3-(cyanomethyl)-4-keto-4-[(4S,5R)-2-keto-4-methyl-5-phenyl-oxazolidin-3-yl]butyric acid
(4S,5R)-3-[3-(3,4-Dimethoxyphenyl)propanoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one
4-Methyl-5-phenyl-3-[2-(carboxymethyl)-1-oxo-3-(methoxycarbonyl)propyl]oxazolidinone
(4S,5R)-3-[(2'R,4'S)-1'-OXO-2',4'-DIMETHYL-5'-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-PENTYL]-4-METHYL-5-PHENYL-2-OXAZOLIDINONE
1-(1H-indol-3-yl)-2-[4-(4-nitrophenyl)-1-piperazinyl]-1-propanone
3-[4-(4-chlorophenyl)-1-piperazinyl]-1-(3-methoxyphenyl)-2,5-pyrrolidinedione
1,4-benzenedicarboxylic acid, 2-[[[4-(4-nitrophenyl)-1-piperazinyl]carbonothioyl]amino]-, dimethyl ester
4-thiazolidinone, 5-(2-furanylmethylene)-3-[2-[4-(4-methoxyphenyl)-1-piperazinyl]-2-oxoethyl]-2-thioxo-, (5E)-
(4R,5S)-3-[1-Oxo-3-(1,3-dithian-2-ylidene)-2-methylpropyl]-4-methyl-5-phenyl-2-oxazolidenone
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis, configuration and properties of some new 3,4,5-substituted oxazolidin-2-ones | European Journal of Chemistry | 2011 |